{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:49:13Z","timestamp":1789732153413,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1136\/ijgc-2020-001771","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T17:15:27Z","timestamp":1601486127000},"page":"1672-1677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget\u2019s disease of the vulva"],"prefix":"10.1016","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct01427244","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9631-5693","authenticated-orcid":false,"given":"Michele","family":"Bartoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Scordilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Del Fabro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bortot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Sabrina","family":"Nicoloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bonotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Scalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Andreetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Meacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Fasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sopracordevole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001771_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2016.03.008","article-title":"Paget disease of the vulva","volume":"101","author":"van der Linden","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1136\/ijgc-2020-001771_bb0015","author":"McDaniel","year":"2020"},{"key":"10.1136\/ijgc-2020-001771_bb0020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jcp.2010.077446","article-title":"HER-2\/NEU overexpression in vulvar Paget disease: the Yale experience","volume":"63","author":"Richter","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1136\/ijgc-2020-001771_bb0025","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2007.12.014","article-title":"HER-2\/neu targeting for recurrent vulvar Paget's disease","volume":"111","author":"Karam","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001771_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000333002","article-title":"A case of metastatic extramammary Paget's disease responding to trastuzumab plus paclitaxel combination therapy","volume":"3","author":"Hanawa","year":"2011","journal-title":"Case Rep Dermatol"},{"key":"10.1136\/ijgc-2020-001771_bb0035","article-title":"Dramatic clinical response of relapsed metastatic extramammary Paget's disease to trastuzumab monotherapy","volume":"2012","author":"Wakabayashi","year":"2012","journal-title":"Case Rep Dermatol Med"},{"key":"10.1136\/ijgc-2020-001771_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00204","article-title":"Case of metastatic extramammary Paget disease of the vulva treated successfully with trastuzumab emtansine","author":"Hsieh","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1136\/ijgc-2020-001771_bb0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2559.2010.03665.x","article-title":"HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study","volume":"57","author":"Sek","year":"2010","journal-title":"Histopathology"},{"key":"10.1136\/ijgc-2020-001771_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1346-8138.2009.00676.x","article-title":"Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy","volume":"36","author":"Takahagi","year":"2009","journal-title":"J Dermatol"},{"key":"10.1136\/ijgc-2020-001771_bb0055","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1634\/theoncologist.2014-0054","article-title":"Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ErbB2 S310F","volume":"19","author":"Vornicova","year":"2014","journal-title":"Oncologist"},{"key":"10.1136\/ijgc-2020-001771_bb0060","article-title":"Extramammary Paget's disease in two brothers","volume":"60","author":"Zhang","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1136\/ijgc-2020-001771_bb0065","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10637-016-0329-8","article-title":"Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease","volume":"34","author":"Watanabe","year":"2016","journal-title":"Invest New Drugs"},{"key":"10.1136\/ijgc-2020-001771_bb0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000445827","article-title":"Human epidermal growth factor receptor 2 (HER-2\/neu)-directed therapy for rare metastatic epithelial tumors with HER-2 amplification","volume":"9","author":"Shin","year":"2016","journal-title":"Case Rep Oncol"},{"key":"10.1136\/ijgc-2020-001771_bb0075","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.18632\/oncotarget.27272","article-title":"Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2S310F mutated extramammary Paget's disease","volume":"10","author":"Nordmann","year":"2019","journal-title":"Oncotarget"},{"key":"10.1136\/ijgc-2020-001771_bb0080","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnci\/djh131","article-title":"Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer","volume":"96","author":"Pegram","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24011952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:37:29Z","timestamp":1753223849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24011952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1048891X24011952"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001771","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget\u2019s disease of the vulva","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}